2215p -25.0 -1.1%
Last Trade - 5:01pm
| Market Cap | £795.8m |
| Enterprise Value | £761.4m |
| Revenue | £52.7m |
| Position in Universe | 491st / 1800 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 30th Jun | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 44.8 | 49.8 | 57.8 | 67.1 | 71.4 | 71.5 | 75.4 | 80.5 | +9.8% | ||
| +11.6 | +14.4 | +21.5 | +21.6 | -2.1 | +5.8 | +8.08 | +3.89 | |||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Craneware plc is a United Kingdom-based company, which is engaged in the development, licensing and ongoing support of computer software for the United States healthcare industry. The Company's Value Cycle Solutions span over five product families, which include Patient Engagement, Charge Capture & Pricing, Coding Integrity, Cost Analytics, and Revenue Collection & Retention. Its Patient Engagement solutions include InSight Medical Necessity, Trisus Patient Payment and Patient Charge Estimator. The Charge Capture & Pricing solutions include Chargemaster Toolkit Discovery Viewer; Physician Revenue Toolkit, Physician Management Toolkit and Physician Revenue Toolkit-Corporate; Pricing Analyzer; Reference Plus; Pharmacy ChargeLink; Supplies ChargeLink, and Supporting Modules. Its Coding Integrity solutions include Trisus Claims Informatics and Bill Analyzer. Its Revenue Recovery & Retention solutions include InSight Audit and InSight Denials. It also offers professional services.
| Last Annual | June 30th, 2020 |
| Last Interim | December 31st, 2020 |
| Incorporated | May 19, 1999 |
| Public Since | September 13, 2007 |
| No. of Shareholders: | n/a |
| No. of Employees: | 352 |
| Sector | Technology |
| Industry | Software & IT Services |
| Index | FTSE Aim All Share , FTSE Aim 100 , |
| Exchange | London Stock Exchange (AIM) |
| Shares in Issue | 35,526,539 |
| Free Float | (0.0%) |
| Eligible for |
✓
ISAs
✓
SIPPs
|
| Address | 1 Tanfield, EDINBURGH, EH3 5DA, United Kingdom |
| Web | https://public.craneware.com/ |
| Phone | +44 131 5503100 |
| Contact | Caroline Forde (Investor Relations Contact Officer) |
| Auditors | PricewaterhouseCoopers LLP |
As of 5:01pm, shares in Craneware are trading at 2215p, giving the company a market capitalisation of £795.8m. This share price information is delayed by 15 minutes.
Shares in Craneware are currently trading at 2215p and the price has moved by 36.59% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Craneware price has moved by 12.88% over the past year.
Of the analysts with advisory recommendations for Craneware, there are there are currently 3 "buy" , 1 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Craneware is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Craneware is scheduled to issue upcoming financial results on the following dates:
The Craneware dividend yield is 1.12% based on the trailing twelve month period.
Last year, Craneware paid a total dividend of 0.35, and it currently has a trailing dividend yield of 1.12%. Looking ahead, Craneware has not announced an ex-dividend date yet.
Craneware has yet to annouce their ex-dividend date. The historic dividend yield on Craneware shares is currently 1.12%.
To buy shares in Craneware you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Craneware are currently trading at 2215p, giving the company a market capitalisation of £795.8m.
Here are the trading details for Craneware:
Based on an overall assessment of its quality, value and momentum, Craneware is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in Craneware are currently priced at 2215p. At that level they are trading at 22.7% discount to the analyst consensus target price of 2,865.46.
Analysts covering Craneware currently have a consensus Earnings Per Share (EPS) forecast of 0.669 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Craneware. Over the past six months, the relative strength of its shares against the market has been -9.11%. At the current price of 2215p, shares in Craneware are trading at 1.51% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Craneware PE ratio based on its reported earnings over the past 12 months is 48.77. The shares are currently trading at 2215p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Craneware's management team is headed by:
Here are the top five shareholders of Craneware based on the size of their shareholding:
